Text Size

Comparing a Closing System Without a Needle With Positive Pressure to a Heparin Lock With Positive Pressure

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00386451
First received: October 10, 2006
Last updated: April 24, 2009
Last verified: April 2009
History of Changes
  Purpose

A prospective randomized study to compare 2 groups:

  • heparine lock with positive pressure
  • lock without a needle with positive pressure

Condition Intervention
Neoplasms
 Device: Catheter locking systems

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Prospective Study Which Compares the Use of a Closing System Without a Needle and With Positive Pressure to a Heparin Lock With Positive Pressure for Patients With a Catheter for Chemotherapy

Resource links provided by NLM:

Drug Information available for: Heparin
U.S. FDA Resources

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Clinical evaluation

Estimated Enrollment: 60
Study Start Date: November 2006
Study Completion Date: July 2007
Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Oncological patients who require intravenous chemotherapy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00386451

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Caren Randon, MD University Hospital, Ghent
  More Information

Additional Information:
Website University Hospital Ghent  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Caren Randon, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00386451     History of Changes
Other Study ID Numbers: 2006/331
Study First Received: October 10, 2006
Last Updated: April 24, 2009
Health Authority: Belgium: Institutional Review Board

Keywords provided by University Hospital, Ghent:
Intravenous chemotherapy

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on May 19, 2013